Conagra Brands (CAG) Stock: Insiders Buy Over $600K Amid Sharp Decline

TLDR

• A pair of Conagra directors acquired 42,500 shares collectively on April 14, investing approximately $609,000 with the stock trading close to its annual bottom.
• Shares have declined 17% year-to-date in 2026, pressured by volume declines, shrinking margins, and reduced full-year guidance.
• Third-quarter results disappointed with earnings per share of $0.39 versus expectations of $0.40 and sales declining 1.9% compared to the prior year.
• Morgan Stanley reduced its price objective to $15 from $17 this Thursday while maintaining an “equal weight” stance.
• The consensus among analysts stands at “Reduce” with a mean price target of $15.80 — comprising 1 Buy, 13 Hold, and 4 Sell recommendations.

Two members of Conagra’s board recently demonstrated their confidence by making substantial share purchases. On April 14, Director Richard H. Lenny acquired 25,000 CAG shares at $14.34 apiece, totaling $358,500. That same day, Director John J. Mulligan scooped up 17,500 shares at $14.31 each, spending $250,425.

Conagra Brands, Inc., CAG

Their collective investment of approximately $609,000 occurred while shares traded near the 12-month low of $14.04. Mulligan’s transaction increased his stake in the company by 542%. Following his purchase, Lenny’s holdings now total 229,340 units with a market value approaching $3.3 million.

The context surrounding these purchases is significant. CAG’s recent selloff accelerated on April 9 following BNP Paribas’ downgrade from Outperform to Neutral, accompanied by a price target reduction from $19 to $16. Shares closed beneath $16 that very day.

Disappointing Quarterly Results Compound Concerns

Earlier in April, Conagra released fiscal third-quarter financials that fell short of Wall Street projections. The packaged foods giant delivered earnings per share of $0.39, missing the consensus estimate of $0.40 by one cent. Sales reached $2.79 billion, marginally surpassing the anticipated $2.76 billion.

However, the modest revenue beat provided little comfort. Total sales slipped 1.9% from the year-ago period, while earnings per share of $0.51 in the comparable quarter last year highlighted a substantial decline. The company also lowered its full fiscal year forecast, citing challenging macroeconomic conditions and sustained inflationary headwinds.

Year-to-date, the stock has tumbled 17%. By comparison, the S&P 500 has gained 4.2% during the same timeframe.

Wall Street Maintains Bearish Posture

Analyst sentiment remains decidedly cautious. This Thursday, Morgan Stanley trimmed its price target on CAG from $17 to $15 while retaining an “equal weight” rating. That new target suggests merely 3.6% potential upside from Wednesday’s closing price.

Morgan Stanley joins a chorus of downgrades. JPMorgan lowered its target from $19 to $17 in March. TD Cowen and Deutsche Bank both adjusted their targets down to $14. Stifel made a similar reduction to $15 this week.

According to MarketBeat’s current analyst compilation, CAG carries 1 Buy rating, 13 Hold ratings, and 4 Sell ratings, with a consensus price target of $15.80 and an overall “Reduce” recommendation.

CAG started Thursday’s session at $14.49. The stock’s 50-day moving average stands at $16.75, while the 200-day moving average rests at $17.38, both substantially above current trading levels.

One notable metric: CAG presently offers approximately a 9% dividend yield, representing the highest yield among S&P 500 constituents. The average dividend yield for payers within the index is 2.3%.

Institutional ownership comprises 83.75% of outstanding shares. A handful of smaller investment funds expanded their positions during recent quarters, although the increases were relatively minor in scale.

The post Conagra Brands (CAG) Stock: Insiders Buy Over $600K Amid Sharp Decline appeared first on Blockonomi.